Similarly, the treatment of diabetic monkeys with FGF21 corrected insulin resistance and improved β-cell function[3].These data indicates that FGF21 may serve as promising targets for the treatment of type 2 diabetes mellitus (T2DM). The gene discussed is FGF21; the disease is type 2 diabetes mellitus.